Rocket Pharmaceuticals Statistics

Total Valuation

RCKT has a market cap or net worth of $330.76 million. The enterprise value is $37.94 million.

Market Cap	330.76M
Enterprise Value	37.94M

Important Dates

The next estimated earnings date is Monday, August 4, 2025, after market close.

Earnings Date	Aug 4, 2025
Ex-Dividend Date	n/a

Share Statistics

RCKT has 107.74 million shares outstanding. The number of shares has increased by 13.04% in one year.

Current Share Class	107.74M
Shares Outstanding	107.74M
Shares Change (YoY)	+13.04%
Shares Change (QoQ)	+12.88%
Owned by Insiders (%)	2.73%
Owned by Institutions (%)	70.89%
Float	81.46M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	0.98
PB Ratio	0.80
P/TBV Ratio	0.95
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.19, with a Debt / Equity ratio of 0.06.

Current Ratio	9.19
Quick Ratio	9.01
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-143.20

Financial Efficiency

Return on equity (ROE) is -60.45% and return on invested capital (ROIC) is -37.33%.

Return on Equity (ROE)	-60.45%
Return on Assets (ROA)	-34.80%
Return on Invested Capital (ROIC)	-37.33%
Return on Capital Employed (ROCE)	-62.01%
Revenue Per Employee	n/a
Profits Per Employee	-$862,963
Employee Count	299
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -86.60% in the last 52 weeks. The beta is 0.68, so RCKT's price volatility has been lower than the market average.

Beta (5Y)	0.68
52-Week Price Change	-86.60%
50-Day Moving Average	5.57
200-Day Moving Average	11.60
Relative Strength Index (RSI)	34.13
Average Volume (20 Days)	8,068,584

Short Selling Information

The latest short interest is 12.65 million, so 11.74% of the outstanding shares have been sold short.

Short Interest	12.65M
Short Previous Month	13.94M
Short % of Shares Out	11.74%
Short % of Float	15.52%
Short Ratio (days to cover)	1.88

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-270.22M
Pretax Income	-253.26M
Net Income	-258.03M
EBITDA	-260.11M
EBIT	-270.22M
Earnings Per Share (EPS)	-$2.61

Full Income Statement

Balance Sheet

The company has $318.16 million in cash and $25.35 million in debt, giving a net cash position of $292.81 million or $2.72 per share.

Cash & Cash Equivalents	318.16M
Total Debt	25.35M
Net Cash	292.81M
Net Cash Per Share	$2.72
Equity (Book Value)	412.14M
Book Value Per Share	3.86
Working Capital	289.18M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$208.66 million and capital expenditures -$4.19 million, giving a free cash flow of -$212.85 million.

Operating Cash Flow	-208.66M
Capital Expenditures	-4.19M
Free Cash Flow	-212.85M
FCF Per Share	-$1.98

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RCKT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.04%
Shareholder Yield	-13.04%
Earnings Yield	-78.01%
FCF Yield	-64.35%

Dividend Details

Analyst Forecast

The average price target for RCKT is $19.68, which is 541.04% higher than the current price. The consensus rating is "Buy".

Price Target	$19.68
Price Target Difference	541.04%
Analyst Consensus	Buy
Analyst Count	11
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-34.44%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1